Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Wolff Parkinson White Syndrome Companies

ID: MRFR/HC/2880-HCR
200 Pages
Satyendra Maurya
Last Updated: February 16, 2025
Wolff-Parkinson-White (WPW) syndrome is a heart condition characterized by an extra electrical pathway in the heart that can cause rapid heartbeats (tachycardia). Companies related to Wolff-Parkinson-White syndrome may be involved in medical devices, treatments, or research associated with cardiac arrhythmias.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Wolff Parkinson White Syndrome Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)5.88%
2024 Market Size$ 400 Million
2025 Market Size$ 423.52 Million
2035 Market Size$ 749.92 Million
Key Players
Abbott Laboratories
Medtronic
Boston Scientific
Johnson & Johnson
Biosense Webster
Siemens Healthineers
Opportunities
  • Expansion of Healthcare Infrastructure
  • Growing Awareness and Education Initiatives
  • Rising Investment in Cardiovascular Research

Top Industry Leaders in the Wolff Parkinson White Syndrome Market

Wolff Parkinson White syndrome Market
ย 

Latestย Wolff Parkinson White syndromeย Companiesย Updates:

Abbott (US): Announced FDA approval for its new Carto 3โ„ข System with Surround Sound technology in July 2023, potentially offering improved mapping and navigation capabilities during ablation procedures, which are sometimes used to treat WPW.

Boston Scientific (US): Received CE Mark approval for its TactiCathยฎ Contact Force Sensing Catheter in September 2023, which may enhance safety and efficacy of catheter ablation procedures, including those for WPW.

Biosense Webster (US): Highlighted its CARTOSยฎ System's role in complex cardiac ablation procedures, including WPW, in its recent clinical study presentations.

CardioNet (US): Launched its new Remote Patient Monitoring (RPM) platform for patients with arrhythmias, including those with WPW, in October 2023, enabling continuous monitoring and early detection of potential complications.

Philips (Netherlands): Showcased its advanced ECG devices and AI-powered analysis tools for accurate diagnosis of arrhythmias, including WPW, at its recent medical conference participation.

List ofย Wolff Parkinson White Syndromeย Key companies in the market:

  • AngioDynamics
  • Medtronic
  • Boston Scientific Corporation
  • St. Jude Medical, LLC
  • Abbott
  • GlaxoSmithKline LLC
  • Teva Pharmaceutical Industries
  • Sanofi S.A.
  • Novartis International AG